Latest News

It looks like Franklin Financial Services Corporation ( NASDAQ:FRAF ) is about to go ex-dividend in the next 4 days...

Investors may wish to note that the Non-Executive Director of CanAlaska Uranium Ltd. , Peter Dasler, recently netted...

As you might know, West Bancorporation, Inc. ( NASDAQ:WTBA ) last week released its latest full-year, and things did...

Key Insights George Weston's estimated fair value is CA$90.47 based on 2 Stage Free Cash Flow to Equity Current share...

The board of First Interstate BancSystem, Inc. ( NASDAQ:FIBK ) has announced that it will pay a dividend of $0.47 per...

Lazard, Inc.'s ( NYSE:LAZ ) investors are due to receive a payment of $0.50 per share on 20th of February. This means...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Methanex fair value estimate is CA$103 Current share price of...

It's been a good week for Civista Bancshares, Inc. ( NASDAQ:CIVB ) shareholders, because the company has just released...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Simplex Holdings (TSE:4373) has moved into focus after reporting robust revenue and profit growth for the nine months to December 31, 2025, launching a four-for-one stock split and announcing a sizable new share repurchase program. See our latest analysis for Simplex Holdings. Despite the latest earnings beat, stock split and new buyback plan, Simplex Holdings’ 30 day share price return of 8.75% and 90 day share price return of 10.79% show recent momentum cooling. This comes even as the 1...

Omega Healthcare Investors (OHI) is back in focus after Wells Fargo cut its rating to Equal Weight and trimmed its target, arguing the REIT’s valuation looks full at current prices for now. See our latest analysis for Omega Healthcare Investors. At a share price of $43.88, Omega Healthcare Investors has seen modest recent moves, with a 4.5% 90 day share price return and a 26.9% 1 year total shareholder return. This indicates that momentum has been building over the longer term despite shorter...

Why Karnov Group’s new buyback matters Karnov Group (OM:KAR) has started repurchasing its series A shares under a SEK 500 million buyback running from January 12 to February 11, 2026, after shareholder approval at an Extraordinary General Meeting. The mandate allows the company to buy back up to 4.99% of its issued share capital, with a stated goal of optimizing its capital structure and potentially improving value for remaining shareholders over time. See our latest analysis for Karnov...

If you are wondering whether KLA's current share price still offers value after a strong run, this article will walk through what the numbers actually say about the stock. Over the last year, KLA returned 95.1%, with a 12.0% gain over the past month but a 5.6% decline in the last week, which may have shifted how investors think about both its upside and risk. Recently, KLA has been in focus as part of broader interest in semiconductor and chip equipment companies, with headlines frequently...

The Board of Directors of The Gorman-Rupp Company recently declared a quarterly cash dividend of US$0.19 per share, payable on March 10, 2026, to shareholders of record as of February 13, 2026. This dividend decision comes alongside evidence of strong multi-year revenue, backlog, and earnings expansion, suggesting the payout is being supported by solid underlying business momentum. Next, we will consider how this combination of a US$0.19 quarterly dividend and robust backlog growth shapes...

We note that the Midland States Bancorp, Inc. ( NASDAQ:MSBI ) Chief Information Officer, Kyle Mooney, recently sold...

In late January 2026, Medicare confirmed it would sharply scale back coverage of telehealth services to mainly rural areas and specific mental health uses, raising fresh questions about demand for Teladoc Health’s virtual care offerings. While Teladoc’s revenue base is still largely tied to commercial health plans rather than Medicare, the policy shift amplifies existing concerns about its BetterHelp user declines, competition and path to profitability. We’ll now examine how the Medicare...

Incyte (NasdaqGS:INCY) received a positive opinion from the European Medicines Agency's CHMP for Zynyz (retifanlimab) with chemotherapy as a first-line treatment for advanced squamous cell carcinoma of the anal canal. The opinion is based on Phase 3 data showing improved outcomes without new safety signals in this patient group. The CHMP decision is an important step in the EU regulatory process and could support broader availability of Zynyz for eligible patients. For you as an investor...

In January 2026, Bristow Group Inc. completed a private offering of US$500,000,000 in 6.750% senior secured notes due 2033, refinanced its 6.875% senior secured notes due 2028, and extended its asset-based revolving credit facility to 2031 with revised commitments. Days earlier, Electra.aero announced a binding pre-delivery payment agreement giving Bristow the first-year production delivery slots for Electra's EL9 hybrid-electric aircraft, highlighting Bristow's early move into...

Why KomeriLtd (TSE:8218) is back on investors’ radar KomeriLtd (TSE:8218) has drawn fresh attention after releasing nine month results to December 31, 2025, alongside full year earnings guidance to March 31, 2026, giving investors clearer visibility on expected revenue and profit. See our latest analysis for KomeriLtd. Alongside the new earnings guidance and the completion of its ¥1,956.47 million buyback program in January, KomeriLtd’s 1-year total shareholder return of 10.27% contrasts with...

Recent share performance and business snapshot Wynn Resorts (WYNN) has drawn investor attention after a period of mixed share performance, with the stock showing negative returns over the past week, month, and past 3 months, but a positive 1 year total return. The company reports revenue of US$7.1b and net income of US$504.3m, with both revenue and net income growth reported on an annual basis. Its value score of 4 and current price of US$107.45 give investors a starting point for assessing...

If you are wondering whether Albemarle's current share price still lines up with its fundamentals, you are in the right place for a clear look at value. Albemarle's stock has moved sharply in both directions recently, with a 10% decline over the last 7 days, an 18.6% gain over the last 30 days, and a 106.9% return over the last year. Over a 3 year period the return sits at a 37.9% decline, and over 5 years the return is 15.2%. Recent coverage around Albemarle has focused on its role in...

Roper Technologies (ROP) just closed out 2025 with higher year-over-year revenue and free cash flow, but its latest earnings release, softer 2026 guidance, and segment pressures have clearly weighed on recent investor sentiment. See our latest analysis for Roper Technologies. The share price reaction has been sharp, with a 7 day share price return of 8.93% and a 30 day share price return of 14.57%, contributing to a 1 year total shareholder return of 35.08%. This may indicate fading momentum...

In late January 2026, Alamos Gold reported fresh exploration results showing extensions of higher-grade gold mineralization at its Young-Davidson mine and further mineralization growth at the Lynn Lake and Qiqavik projects in Canada. The concentration of newly identified high-grade zones close to existing underground infrastructure, combined with expanding satellite and greenfield prospects, materially strengthens the company’s long-term project pipeline. We’ll now examine how this expansion...

Johnson & Johnson (JNJ) is back in focus after a run of upbeat news, including strong fourth quarter and full year 2025 results, fresh 2026 sales guidance, and new FDA approval for DARZALEX FASPRO. See our latest analysis for Johnson & Johnson. Those updates have come alongside a strong share price run, with a 90 day share price return of 22.01% and a 1 year total shareholder return of 53.93%. This suggests that momentum has been building as investors reassess growth potential and litigation...